Prospective highlights of serum glycoproteins in spontaneous tolerance after orthotopic liver transplantation

Clinica Chimica Acta

Volumn 412, Issue 7-8, 2011, Pages 604-613

  Pan, Tai Long ^a   Wang, Pei Wen ^a   Chen, Shui Ten ^b   Fang, Jia You ^a,c   Hsu, Teng Kuei ^b   Sintupisut, Nardnisa ^b   Goto, Shigeru ^d   Chen, Chao Long ^d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c Chang Gung Institute in Technology   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Allograft rejection; Fucosylation; IL 6; Immunosuppressive; Orthotopic liver transplantation; Proteomics

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN; HAPTOGLOBIN; HEMOPEXIN; INTERLEUKIN 6;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FUCOSYLATION; GRAFT REJECTION; IMMUNE RESPONSE; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SEQUENCE; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; LIVER TRANSPLANTATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROSPECTIVE STUDIES; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79551496433     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.014     Document Type: Article

References (35)

1. Mehrabi A., Fonouni H., Müller S.A., Schmidt J. Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg 2008, 393:245-260.
2. Calmus Y. Immunosuppression after liver transplantation. Presse Méd 2009, 38:1307-1313.
3. Seyfert-Margolis V., Feng S. Tolerance: is it achievable in pediatric solid organ transplantation?. Pediatr Clin N Am 2010, 57:523-538.
4. Kamada N., Brons G., Davies H.S. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980, 29:429-431.
5. Andrzejewski W., Brölsch C. Postoperative reactions of rats after orthotopic liver transplantation: a model for the human response? A histological and biochemical study. Eur Surg Res 1982, 14:428-439.
6. Crispe I.N., Giannandrea M., Klein I., John B., Sampson B., Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol Rev 2006, 213:101-118.
7. Bishop G.A., Wang C., Sharland A.F., McCaughan G. Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunol Cell Biol 2002, 80:93-100.
8. Hamrita B., Chahed K., Trimeche M., et al. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clin Chim Acta 2009, 404:111-118.
9. Marouga R., David S., Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 2005, 382:669-678.
10. Hoffman S.A., Joo W.A., Echan L.A., Speicher D.W. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 849:43-52.
11. Narisada M., Kawamoto S., Kuwamoto K., et al. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells. Biochem Biophys Res Commun 2008, 377:792-796.
12. Becker D.J., Lowe J.B. Fucose: biosynthesis and biological function in mammals. Glycobiology 2003, 13:41R-53R.
13. Gornik O., Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers 2008, 25:267-278.
14. Park S.Y., Yoon S.J., Jeong Y.T., et al. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer 2010, 126:142-155.
15. Pan T.L., Wang P.W., Huang C.C., Goto S., Chen C.L. Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology 2004, 113:57-64.
16. Knechtle S.J., Kwun J. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 2009, 29:91-101.
17. Mahesh B., Leong H.S., McCormack A., Sarathchandra P., Holder A., Rose M.L. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 2007, 170:1415-1427.
18. Yalcindag A., He R., Laouini D., et al. The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen. J Allergy Clin Immunol 2006, 117:1455-1461.
19. Sadhu C., Ting H.J., Lipsky B., et al. CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. J Leukoc Biol 2007, 81:1395-1403.
20. Sierra F., Walter R., Vautravers P., Guigoz Y. Identification of several isoforms of T-kininogen expressed in the liver of aging rats. Arch Biochem Biophys 1995, 322:333-338.
21. Dellalibera-Joviliano R., Joviliano E.E., Évora P.R.B. Determination of kininogens levels and kallikrein/kininase II activities in patients with thromboangiitis obliterans. Scand J Immunol 2010, 72:128-133.
22. Giurgea N., Constantinescu M.I., Stanciu R., Suciu S., Muresan A. Ceruloplasmin - acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med Sci Monit 2005, 11:RA48-51.
23. Wang Y., Kinzie E., Berger F.G., Lim S.K., Baumann H. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep 2001, 6:379-385.
24. He S., Atkinson C., Qiao F., Cianflone K., Chen X., Tomlinson S. A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J Clin Invest 2009, 119:2304-2316.
25. Baía C.E., Abdala E., Massarollo P., Beduschi T., Palma T.M., Mies S. Inflammatory cytokines during liver transplantation: prospective randomized trial comparing conventional and piggyback techniques. Hepatogastroenterology 2009, 56:1445-1451.
26. Arnold J.N., Saldova R., Hamid U.M., Rudd P.M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8:3284-3293.
27. Ding C., Cicuttini F., Li J., Jones G. Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opin Investig Drugs 2009, 18:1457-1466.
28. Chen R.H., Chang M.C., Su Y.H., Tsai Y.T., Kuo M.L. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem 1999, 274:23013-23019.
29. Gao B. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol 2004, 34:59-65.
30. Haga S., Terui K., Zhang H.Q., et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003, 112:989-998.
31. Chen L.P., Zhang Q.H., Chen G., Qian Y.Y., Shi B.Y., Dong J.H. Rapamycin inhibits cholangiocyte regeneration by blocking interleukin-6-induced activation of signal transducer and activator of transcription 3 after liver transplantation. Liver Transplant 2010, 16:204-214.
32. El-Ghmati S.M., Arredouani M., Van Hoeyveld E.M., Ceuppens J.L., Stevens E.A. Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation. Scand J Immunol 2002, 55:352-358.
33. Hanasaki K., Powell L.D., Varki A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem 1995, 270:7543-7550.
34. Artz A.S., Wickrema A., Dinner S., Godley L.A., Kocherginsky M., Odenike O., Rich E.S., Stock W., Ulaszek J., Larson R.A., van Besien K. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008, 14:1209-1216.
35. Crumley A.B., McMillan D.C., McKernan M., Going J.J., Shearer C.J., Stuart R.C. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 2006, 94:1568-1571.